F5-peptide enhances the efficacy of the non-hormonal male contraceptive adjudin

OBJECTIVE. The bioavailability of the non-hormonal male contraceptive adjudin is low in rats due to the blood-testis barrier (BTB). This study was designed to examine if F5-peptide, an endogenously produced reversible BTB modifier, could enhance the bioavailability of adjudin to affect spermatogenes...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Contraception
Prif Awduron: Chen, Haiqi, Mruk, Dolores, Wong, Chris K.C., Silvestrini, Bruno, Cheng, C. Yan
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2019
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6790069/
https://ncbi.nlm.nih.gov/pubmed/30763581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.contraception.2019.01.007
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg